Canadian Blood and Marrow Transplant Group

Chronic GVHD Training Session:
Evaluating Therapeutic Response in Chronic GVHD Treatment Trials
2010 Tandem Meeting, Orlando, FL
Friday, 2/26, 8pm-10pm
Panzacola F3-F4

RSVP Require (pleas see details below).

I. Goal

To provide training on the NIH Response Criteria, with a focus on skin and mouth manifestations, using pictures of actual patient presentations and demonstrations of functional measures

II. Target Audience

Clinicians already familiar with chronic GVHD who will be responsible for completing study forms or collecting functional measures from patients. At the conclusion of this session, participants should feel more comfortable collecting NIH response criteria.

III. Agenda

8:00 pm Welcome and Overview

Presenter: Stephanie Lee, MD


8:05 to 8:15 Introduction to Diagnosis and Staging, and Evaluation of Therapeutic Response

a. cGVHD as an endpoint in clinical trials (diagnosis, late acute vs classic classification, and organ scoring with global severity determination)

b. Purpose of response criteria


Presenter: Steven Z. Pavletic, MD

Component Evaluations in Chronic GVHD Response Assessment


8:15-8:45 Dermatologic Evaluation of the Patient with Chronic GVHD

Presenter: Edward Cowen, MD


8:45-9:15 Oral Evaluation of the Patient with Chronic GVHD

Presenter: M. Elvira P. Correa, DDS, MSD, PhD


9:15-9:30 Functional Performance Evaluation and Patient Reported Outcomes

Presenter: Sandra Mitchell, PhD, CRNP


9:30-9:35 Pediatric Aspects of Therapeutic Response Evaluation

Presenter: David Jacobsohn, MD


9:35-9:45 Putting It All Together: Chronic GVHD Response Assessment Tools

Presenter: David Jacobsohn, MD


9:45-10:00 Questions and Discussion


Please only sign up if you are reasonably certain you will come. The session will be videotaped and also available on the Web after the meeting.
To reserve your space, please RSVP to Anne Thompson: (lthompsa@fhcrc.org) with your name, institution, and email address. If you later decide you are not able to attend, please let Anne know so we can free up the space for others.

This website is supported by an unrestricted educational grant provided by: